secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001558370-25-008924
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm stockholders elect two Class II directors, approve officer exculpation amendment
--------------------------------------------------------------------------------

- Jennifer Good (55.6M votes for) and Edward T. Mathers (35.2M for) elected as Class II directors.
- Ernst & Young ratified as independent auditor for FY2025 with 60.6M votes for, 158k against.
- Non-binding advisory vote on executive compensation approved (40.9M for, 18.1M against).
- Amendment to certificate of incorporation to provide officer exculpation approved (55.5M for, 3.5M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000155837025008924/0001558370-25-008924-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000155837025008924/rytm-20250624x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-008924

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer